+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Thyroid Eye Disease Treatments Market by Treatment Type (Medical Treatment, Surgical Treatment), Route of Administration (Intravenous, Oral, Topical), Type, Diagnosis, End-User - Global Forecast 2025-2030- Product Image
Thyroid Eye Disease Treatments Market by Treatment Type (Medical Treatment, Surgical Treatment), Route of Administration (Intravenous, Oral, Topical), Type, Diagnosis, End-User - Global Forecast 2025-2030- Product Image
Sale

Thyroid Eye Disease Treatments Market by Treatment Type (Medical Treatment, Surgical Treatment), Route of Administration (Intravenous, Oral, Topical), Type, Diagnosis, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5012989
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The thyroid eye disease treatments market is evolving swiftly, driven by scientific advances, increased clinical collaboration, and a dynamic regulatory environment. Stakeholders face a complex landscape shaped by new therapeutic approaches, refined diagnostics, and shifting supply chain realities, underscoring the need for timely insights and strategic direction.

Market Snapshot: Thyroid Eye Disease Treatments Market

The Thyroid Eye Disease Treatments Market grew from USD 2.67 billion in 2024 to USD 2.83 billion in 2025. It is expected to continue growing at a CAGR of 5.94%, reaching USD 3.78 billion by 2030. Market expansion is sustained by innovative targeted therapies, improved diagnostics, and evolving patient care models, as organizations invest in research and optimize supply networks to meet unmet clinical needs.

Scope & Segmentation

  • Treatment Types: Medical therapies and surgical interventions, including corticosteroids, immunosuppressants, monoclonal antibodies, thyroid hormone control agents, tyrosine kinase inhibitors, eyelid surgery, orbital decompression, and strabismus procedures.
  • Routes of Administration: Intravenous, oral, and topical formulations support diverse clinical scenarios and patient preferences.
  • Disease Types: Type I and Type II thyroid eye disease require differentiated management strategies reflecting progression and risk.
  • Diagnostic Modalities: Blood tests, imaging techniques, orbital ultrasound, and radioactive iodine uptake tests enhance accuracy and guide monitoring.
  • End-Users: Hospitals, outpatient centers, and specialty clinics vary in their capacity for interdisciplinary and advanced intervention delivery.
  • Geographic Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (including key economies like Germany, UK, France, and emerging markets in the Middle East and Africa), and Asia-Pacific (China, India, Japan, Australia, South Korea, and Southeast Asian countries).
  • Leading Companies: Abbott Laboratories, AbbVie Inc., ACELYRIN, INC., Amgen Inc., argenx SE, Bausch & Lomb, Biocon, BioXpress Therapeutics, Cipla, Dr. Reddy’s Laboratories, Eli Lilly, Roche, Genmab, GSK, H. Lundbeck, Hetero, Immunovant, Intas, J&J, Lupin, Merck KGaA, Novartis, Pfizer, Regeneron, Sling Therapeutics, Teva, Viridian Therapeutics.

Key Takeaways

  • Introduction of precision biologics and small-molecule therapies is gradually transforming standard treatment protocols and patient stratification approaches for thyroid eye disease.
  • Cross-disciplinary clinical models involving endocrinologists, ophthalmologists, and surgeons support the coordinated management of complex cases, improving patient functional and aesthetic outcomes.
  • Investments in diagnostic technologies and imaging analytics are enhancing early disease detection and personalized therapy planning.
  • Regional variation in adoption rates stems from differences in reimbursement landscapes, regulatory frameworks, and access to advanced care—particularly relevant across Europe, the Middle East, and emerging Asian health systems.
  • Collaboration among industry, academic research centers, and advocacy groups is accelerating innovative treatment development and regulatory engagement.
  • Emerging technologies, including digital therapeutics and sustained-release drug delivery, are attracting investment and may expand patient-centric care pathways.

Tariff Impact

Recent tariff implementations in the United States have increased the cost base for imported active pharmaceutical ingredients and specialized equipment. These pressures have prompted adjustments in pricing strategies, procurement processes, and contractual negotiations. In response, some manufacturers are pursuing nearshoring to reduce exposure to future policy shifts and minimize supply disruptions. Industry advocacy for tariff exemptions and resilient supply chain models remains ongoing.

Methodology & Data Sources

This report integrates primary interviews with leading clinicians, institutional stakeholders, and industry experts, alongside extensive secondary research from peer-reviewed literature, clinical registries, and regulatory filings. Quantitative analysis utilizes anonymized patient registries and robust statistical models, while qualitative insights contextualize findings within broader healthcare trends and economic factors.

Why This Report Matters

  • Enables decision-makers to benchmark current strategies and anticipate emerging regulatory, technological, and competitive shifts within the thyroid eye disease treatments market.
  • Provides actionable guidance for optimizing resource allocation, supporting innovation, and sustaining patient access amid evolving clinical and policy environments.
  • Equips senior leaders with validated segmentation insights for effective market entry, partnership formation, and technology adoption decisions.

Conclusion

The thyroid eye disease treatments market is transitioning toward more targeted, collaborative, and resilient care models. This report provides stakeholders with the strategic context and insights needed to make informed decisions, drive innovation, and enhance patient outcomes in a dynamic landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Real-world efficacy and safety insights from long-term teprotumumab patient registries
5.2. Emerging small molecule therapies targeting orbital fibroblasts in thyroid eye disease
5.3. Impact of biosimilar development on cost accessibility of monoclonal antibody treatments for TED
5.4. Role of advanced imaging biomarkers in stratifying patients for personalized TED therapy
5.5. Pipeline innovation in oral anti-inflammatory agents reducing corticosteroid dependency in TED management
5.6. Regulatory landscape evolution for expedited approval pathways in rare ophthalmic indications like TED
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Thyroid Eye Disease Treatments Market, by Treatment Type
8.1. Introduction
8.2. Medical Treatment
8.2.1. Corticosteroids
8.2.2. Immunosuppressants
8.2.3. Monoclonal Antibodies
8.2.4. Thyroid Hormone Control
8.2.5. Tyrosine Kinase Inhibitors
8.3. Surgical Treatment
8.3.1. Eyelid Surgery
8.3.2. Orbital Decompression Surgery
8.3.3. Strabismus Surgery
9. Thyroid Eye Disease Treatments Market, by Route of Administration
9.1. Introduction
9.2. Intravenous
9.3. Oral
9.4. Topical
10. Thyroid Eye Disease Treatments Market, by Type
10.1. Introduction
10.2. Type I TED
10.3. Type II TED
11. Thyroid Eye Disease Treatments Market, by Diagnosis
11.1. Introduction
11.2. Blood Test
11.3. Imaging Test
11.4. Orbital Ultrasound
11.5. Radioactive Iodine Uptake Test
12. Thyroid Eye Disease Treatments Market, by End-User
12.1. Introduction
12.2. Hospitals
12.3. Outpatient Centers
12.4. Specialty Clinics
13. Americas Thyroid Eye Disease Treatments Market
13.1. Introduction
13.2. United States
13.3. Mexico
13.4. Argentina
13.5. Canada
13.6. Brazil
14. Europe, Middle East & Africa Thyroid Eye Disease Treatments Market
14.1. Introduction
14.2. Spain
14.3. Norway
14.4. Russia
14.5. South Africa
14.6. Germany
14.7. Turkey
14.8. Italy
14.9. Denmark
14.10. Poland
14.11. United Arab Emirates
14.12. United Kingdom
14.13. Egypt
14.14. Nigeria
14.15. Israel
14.16. Switzerland
14.17. Qatar
14.18. France
14.19. Netherlands
14.20. Sweden
14.21. Saudi Arabia
14.22. Finland
15. Asia-Pacific Thyroid Eye Disease Treatments Market
15.1. Introduction
15.2. India
15.3. Japan
15.4. Australia
15.5. Singapore
15.6. China
15.7. Philippines
15.8. Malaysia
15.9. Taiwan
15.10. Thailand
15.11. Vietnam
15.12. South Korea
15.13. Indonesia
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. AbbVie Inc.
16.3.3. ACELYRIN, INC.
16.3.4. Amgen Inc.
16.3.5. argenx SE
16.3.6. Bausch & Lomb Incorporated
16.3.7. Biocon Limited
16.3.8. BioXpress Therapeutics SA
16.3.9. Cipla Limited
16.3.10. Dr. Reddy’s Laboratories Ltd.
16.3.11. Eli Lilly and Company
16.3.12. F. Hoffmann-La Roche AG
16.3.13. Genmab A/S
16.3.14. GlaxoSmithKline PLC
16.3.15. H. Lundbeck A/S
16.3.16. Hetero Drugs Limited
16.3.17. Immunovant, Inc.
16.3.18. Intas Pharmaceuticals Ltd.
16.3.19. Johnson & Johnson Services Inc.
16.3.20. Lupin Limited
16.3.21. Merck KGaA
16.3.22. Novartis AG
16.3.23. Pfizer, Inc.
16.3.24. Regeneron Pharmaceuticals, Inc.
16.3.25. Sling Therapeutics, Inc.
16.3.26. Teva Pharmaceutical Industries Ltd.
16.3.27. Viridian Therapeutics, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. THYROID EYE DISEASE TREATMENTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2024 VS 2030 (%)
FIGURE 12. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. THYROID EYE DISEASE TREATMENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. THYROID EYE DISEASE TREATMENTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. THYROID EYE DISEASE TREATMENTS MARKET: RESEARCHAI
FIGURE 26. THYROID EYE DISEASE TREATMENTS MARKET: RESEARCHSTATISTICS
FIGURE 27. THYROID EYE DISEASE TREATMENTS MARKET: RESEARCHCONTACTS
FIGURE 28. THYROID EYE DISEASE TREATMENTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. THYROID EYE DISEASE TREATMENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY THYROID HORMONE CONTROL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY THYROID HORMONE CONTROL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYROSINE KINASE INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYROSINE KINASE INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY EYELID SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY EYELID SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ORBITAL DECOMPRESSION SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ORBITAL DECOMPRESSION SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY STRABISMUS SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY STRABISMUS SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE I TED, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE I TED, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE II TED, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE II TED, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY BLOOD TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY IMAGING TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY IMAGING TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ORBITAL ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ORBITAL ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY RADIOACTIVE IODINE UPTAKE TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY RADIOACTIVE IODINE UPTAKE TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY OUTPATIENT CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY OUTPATIENT CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 99. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 100. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 101. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 102. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 103. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 104. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 105. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 106. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 107. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 108. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 109. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 110. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 111. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 112. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 113. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 114. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 117. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 118. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 119. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 120. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 127. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 128. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 129. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 130. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 131. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 132. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 133. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 134. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 135. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 136. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 137. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 138. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 139. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 140. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 171. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 172. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 173. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 174. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 175. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 176. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 177. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 180. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 181. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 182. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 183. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 184. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 185. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 186. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 187. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 188. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 189. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 190. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 191. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 192. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 193. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 194. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 195. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 196. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 197. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 198. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 199. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 200. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 201. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 202. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 203. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 204. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 214. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 216. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 218. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 222. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 224. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 226. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 227. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 228. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 229. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 230. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 231. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 232. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 233. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 236. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 237. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 238. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 239. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 240. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 241. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 242. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 243. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 244. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 245. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 246. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 247. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 250. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 251. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 252. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 253. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 254. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 255. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 256. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 257. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 258. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 259. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 260. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 261. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 264. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 265. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 266. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 267. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 268. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 269. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 270. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 271. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 272. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 273. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 274. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 275. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 278. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 279. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 280. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 281. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 282. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 283. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 284. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 285. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 286. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 287. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 288. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 289. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 292. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 293. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 294. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 295. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 296. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRAT

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • ACELYRIN, INC.
  • Amgen Inc.
  • argenx SE
  • Bausch & Lomb Incorporated
  • Biocon Limited
  • BioXpress Therapeutics SA
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Genmab A/S
  • GlaxoSmithKline PLC
  • H. Lundbeck A/S
  • Hetero Drugs Limited
  • Immunovant, Inc.
  • Intas Pharmaceuticals Ltd.
  • Johnson & Johnson Services Inc.
  • Lupin Limited
  • Merck KGaA
  • Novartis AG
  • Pfizer, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sling Therapeutics, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viridian Therapeutics, Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.83 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.78 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Global Thyroid Eye Disease Treatment Market (2025 Edition): Analysis By Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, and Other Therapies), Route of Administration, Distribution Channel: Market Insights and Forecast (2021-2031) - Product Image

Global Thyroid Eye Disease Treatment Market (2025 Edition): Analysis By Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, and Other Therapies), Route of Administration, Distribution Channel: Market Insights and Forecast (2021-2031)

  • Report
  • 238 Pages
  • Global
From
Thyroid Eye Disease (TED) Global Market Report 2025 - Product Image

Thyroid Eye Disease (TED) Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Graves' Ophthalmopathy - Pipeline Insight, 2025 - Product Image

Graves' Ophthalmopathy - Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
Diabetic Eye Disease Devices Market by Technology (Fluorescein Angiography, Fundus Camera, Indocyanine Green Angiography), Device Type (Diagnostic Devices, Surgical Instruments, Therapeutic Devices), End User, Application, Distribution Channel - Global Forecast 2025-2030 - Product Image

Diabetic Eye Disease Devices Market by Technology (Fluorescein Angiography, Fundus Camera, Indocyanine Green Angiography), Device Type (Diagnostic Devices, Surgical Instruments, Therapeutic Devices), End User, Application, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Dry Eye Disease Treatment - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Dry Eye Disease Treatment - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From

About the Thyroid Eye Disease Treatment Market

Thyroid Eye Disease (TED) is a rare autoimmune disorder that affects the eyes and surrounding tissues. It is caused by an overactive thyroid gland, which produces antibodies that attack the muscles and fatty tissues around the eyes. Symptoms of TED include bulging eyes, double vision, and dry eyes. Treatment for TED typically involves a combination of medications, surgery, and lifestyle changes. Medications used to treat TED include corticosteroids, immunosuppressants, and antithyroid drugs. Surgery may be used to correct double vision, reduce the bulging of the eyes, and improve the appearance of the eyes. Lifestyle changes such as avoiding smoking, reducing stress, and eating a healthy diet can also help manage the symptoms of TED. Companies in the Thyroid Eye Disease Treatment market include Allergan, Novartis, Pfizer, and Regeneron. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.